Cite
HARVARD Citation
Stacchiotti, S. et al. (2017). Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour. European journal of cancer. pp. 84-92. [Online].